Clinical Trials Directory

Trials / Terminated

TerminatedNCT00167141

Contraception in Normal and Subnormal Men

Hormonal Male Contraception in Men With Normal and Subnormal Semen Parameters

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
41 (actual)
Sponsor
University Hospital Muenster · Academic / Other
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Volunteers with normal and subnormal semen parameters receive a hormonal male contraceptive in order to investigate whether there are differences between normal and subnormal men in terms of suppressibility, rate of azoospermia and reversibility of suppression of spermatogenesis.

Detailed description

Volunteers with normal and subnormal semen parameters receive a hormonal male contraceptive in order to investigate whether there are differences between normal and subnormal men in terms of suppressibility, rate of azoospermia and reversibility of suppression of spermatogenesis. Twenty-five men will be recruited for each group. They will be exposed to hormonal male contraception for six months.

Conditions

Interventions

TypeNameDescription
DRUGinjection of hormonal male contraceptivetestosterone injections 4 times

Timeline

Start date
2005-02-01
Primary completion
2007-12-01
Completion
2008-01-01
First posted
2005-09-14
Last updated
2010-02-02

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00167141. Inclusion in this directory is not an endorsement.